Phospholipase
Phospholipases are enzymes that catalyze the hydrolysis of phospholipids into fatty acids and other lipid mediators. It plays a variety of roles in tumorgenesis , inflammation and brain disorders etc.
Products for Phospholipase
- Cat.No. Product Name Information
- GC45618 (±)-trans-GK563 A GVIA iPLA2 inhibitor
- GC40678 (R)-Bromoenol lactone The phospholipases are an extensive family of lipid hydrolases that function in cell signaling, digestion, membrane remodeling, and as venom components.
- GC40679 (S)-Bromoenol lactone The phospholipases are an extensive family of lipid hydrolases that function in cell signaling, digestion, membrane remodeling, and as venom components.
- GC46352 (S)-DO271 An inactive control for DO264
- GC41782 1,2-bis(heptanoylthio) Glycerophosphocholine Diheptanoyl Thio-PC is a substrate for all phospholipase A2s (PLA2s) with the exception of cPLA2 and PAF-acetyl hydrolase (PAF-AH).
-
GC41808
1,2-Dioctanoyl PC
Phosphatidylcholine (PC) species are a common class of phospholipids that comprise the mammalian cell membrane.
- GC35065 1-Linoleoyl Glycerol 1-Linoleoyl Glycerol is a fatty acid glycerol.
- GC33457 1-Naphthaleneacetic acid (1-Naphthylacetic acid) 1-Naphthaleneacetic acid (1-Naphthylacetic acid) (1-Naphthylacetic acid), a synthetic auxin, can promote plant growth.
- GC42029 1-Palmitoyl-2-linoleoyl PE Phosphatidylethanolamines are important components of cell membranes and biochemical pathways of fatty acid synthesis.
- GC11055 10-Pyrene-PC A substrate for some PLA2s
- GC30561 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide 2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide is a compound that inhibits stress-induced ulcer and low toxicity, and can maintain the content of phospholipase A2 and prostaglandin E2 in ulcerated rats induced by water immersed restrained stress.
- GC65595 3-Nitrocoumarin 3-Nitrocoumarin (3-NC) is a potent and selective Phospholipase C-γ (PLC-γ) inhibitor.
- GC10565 7-hydroxycoumarinyl Arachidonate substrate for cPLA2
- GC42611 7-hydroxycoumarinyl-γ-Linolenate 7-hydroxycoumarinyl-γ-Linolenate is a γ-linolenic acid ester of 7-hydroxycoumarin (umbelliferone) that behaves as a substrate for cPLA2.
- GC46761 9-Oxononanoic Acid An oxidized fatty acid
- GC31355 AA26-9 AA26-9 is a potent and broad spectrum serine hydrolase inhibitor.
-
GC16115
AACOCF3
Inhibitor of cPLA2/anandamide hydrolysis/FAAH
- GC61689 Alminoprofen Alminoprofen (EB-382) is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylpropionic acid class.
- GC16770 Arachidonic Acid Leelamide phospholipase A2 inhibitor
- GC42843 Arachidonoyl thio-PC Arachidonoyl Thio-PC is a substrate for many phospholipase A2s (PLA2s) including sPLA2, cPLA2, and iPLA2.
- GC35390 Aristolochic acid C An alkaloid with anticancer activity
- GC42855 ARN19874 ARN19874 is an inhibitor of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD; IC50 = 33.7 μM).
- GC50726 ASB 14780 ASB 14780 is a 4-phenoxy derivative, the cytosolic Phospholipase A2α (cPLA2α) inhibitor, with an IC50 value of 20 nM.
- GC42885 AX 048 The group IVA phospholipase A2 (PLA2), known as calcium-dependent cytosolic PLA2 (cPLA2), selectively releases arachidonic acid from membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes.
- GC49784 AZD 2716 An sPLA2 inhibitor
- GC67211 BAPTA tetrapotassium BAPTA tetrapotassium is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA tetrapotassium is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA tetrapotassium can also inhibit phospholipase C activity independently of their role as Ca2+ chelators.
- GC11021 Bromoenol lactone Inhibitor of myocardial cytosolic calcium-independent phospholipase A2 (iPLA2)
- GC43161 CAY10502 Phospholipase A2 (PLA2) catalyzes the hydrolysis of phospholipids at the sn-2 position leading to the production of lysophospholipids and free fatty acids.
- GC43179 CAY10590 Phospholipase A2 (PLA2) catalyzes the hydrolysis of fatty acids at the sn-2 position of glycerophospholipids, liberating arachidonic acid for subsequent eicosanoid synthesis.
- GC18691 CAY10594 CAY10594 is an effective inhibitor of phospholipase D2 (PLD2) (IC50 140 nm in vitro and 110 nm in cells).
- GC47049 CAY10641 An inactive alcohol derivative of a highly potent cPLA2 inhibitor
- GC18305 CAY10650 Cytosolic phospholipase A2α (cPLA2α) specifically catalyzes the hydrolysis of arachidonic acid from the sn-2-ester position of membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins and leukotrienes, both important mediators of the inflammatory process.
- GC64388 CCT129957 CCT129957 is an indole derivative and a potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of ~3 μM and a GC50 of 15 μM. CCT129957 inhibits Ca2+ release in squamous carcinoma cells at ~15 μM.
-
GC40545
cis-Parinaric Acid
cis-Parinaric acid is a naturally occurring polyunsaturated fatty acid containing an unusual conjugated (Z,E,E,Z) tetraene.
- GC43305 Compound 48/80 (hydrochloride) Compound 48/80 (hydrochloride) (C48/80 trihydrochloride) is a mixture of condensation products of N-methyl-p-methoxyphenethylamine with formaldehyde.
- GC15877 CP 316819 Selective glycogen phosphorylase inhibitor
- GC16418 CP-91149 Selective inhibitor of glycogen phosphorylase
- GC17851 D609 A competitive inhibitor of PC-specific PLC
- GC12361 Darapladib A reversible inhibitor of Lp-PLA2
- GC45995 DO264 An ABHD12 inhibitor
- GC18141 EA4 rPLA2 inhibitor
- GC30464 Ecopladib (PLA 725) Ecopladib (PLA 725) is a sub-micromolar inhibitor of cytosolic phospholipase A2α (cPLA2α), with IC50s of 0.15 μM and 0.11 μM in the GLU micelle and rat whole blood assays, respectively.
- GC16687 Edelfosine Edelfosine ((R)-ET-18-OCH3) is a ether lipid analog with anti-HIV and antineoplastic activity.
-
GC13620
FIPI
phosholipase D (PLD) inhibitor
- GC43670 FKGK 11 Phospholipase A2 (PLA2) catalyzes the hydrolysis of fatty acids at the sn-2 position of glycerophospholipids, yielding a free fatty acid and a lysophospholipid as products.
- GC43671 FKGK 18 FKGK 18 is an inhibitor of group VIA (GVIA) calcium-independent phospholipase A2 (iPLA2).
- GC43695 Folipastatin Folipastatin is a fungal metabolite produced by A.
-
GC69136
Fuzapladib sodium
Fuzapladib sodium (IS-741 sodium) is an effective orally active inhibitor of phospholipase A2 (phospholipase A2). Fuzapladib sodium can block the adhesion between inflammatory cells and microvascular endothelial cells, inhibit neutrophil infiltration into the pancreas or acute pancreatitis, and has anti-acute pancreatitis effects.
- GC43756 GK187 GK187 is an inhibitor of Group VIA (GVIA) calcium-independent phospholipase A2 (iPLA2), an enzyme involved in basal cell metabolism.
- GC52315 GK241 An sPLA2 (Type IIA) inhibitor
- GC13948 GPi 688 glycogen phosphorylase inhibitor
-
GC12880
GSK 2830371
Orally active, allosteric inhibitor of Wip1 phosphatase
- GC67909 GSK2647544
- GC19186 GW4869 GW4869 is a noncompetitive neutral sphingomyelinase(N-SMase) inhibitor with an IC50 of 1 uM.
- GC11243 Halopemide phospholipase D (PLD) inhibitor
- GC43812 HEPC Thioester analogs of glycerophospholipids, in combination with Ellman's reagent, are convenient colorimetric substrates for the measurement of phospholipase activity.
- GC10162 JJKK 048 monoacylglycerol lipase (MAGL) inhibitor
- GC52080 LEI-110 An AdPLA2 inhibitor
- GC60982 LEI-401 An NAPE-PLD inhibitor
-
GC69371
LFHP-1c
LFHP-1c is a PGAM5 inhibitor that exhibits neuroprotective activity in ischemic stroke. LFHP-1c protects the integrity of the blood-brain barrier from ischemic damage. LFHP-1c binds to endothelial cell PGAM5, inhibits PGAM5 phosphatase activity, and suppresses the interaction between PGAM5 and NRF2. LFHP-1c has protective effects both in vitro and in vivo.
- GC32224 Lp-PLA2 -IN-1 Lp-PLA2 -IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor.
-
GC30610
LY 178002
LY 178002 is a potent inhibitor of 5-lipoxygenase (5-LPO), phospholipase A2, with IC50 of 0.6 μM for 5-lipoxygenase, inhibits cellular production of LTB4 by human polymorphonuclear leukocytes, and shows relatively weak inhibition on cyclooxygenase.
- GC16364 LY 311727 secreted phospholipase A2 (sPLA2) inhibitor
- GC49635 LY433771 An inhibitor of type X sPLA2
- GC18559 Lysophosphatidylethanolamines (egg) Lysophosphatidylethanolamine (LPE) is a naturally-occurring lysophospholipid that can be generated via deacylation of phosphatidylethanolamine by phospholipase A2 (PLA2).
- GC16286 m-3M3FBS PLC activator
-
GC12420
MAFP
cPLA2 and iPLA2 inhibitor, potent FAAH inhibitor
-
GC11631
Melittin
Inhibits Gs and stimulates Gi activity
- GC49546 Melittin (trifluoroacetate salt) The principal cytotoxic component of bee venom
- GC61040 Melittin TFA Melittin TFA is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2.
- GC10645 MJ33 (lithium salt) inhibitor of the acidic, calcium-independent (ai)PLA2 activity of Prdx6
- GC11073 ML 298 hydrochloride phospholipase D2 (PLD2) inhibitor
- GC18039 ML 348 lysophospholipase 1 (LYPLA1) inhibitor
- GC17889 ML 349 lysophospholipase 2 (LYPLA2) inhibitor
- GC44222 ML-298 ML-298 is an inhibitor of phospholipase D2 (PLD2; IC50 = 355 nM).
- GC44223 ML-299 ML-299 is a dual inhibitor of the two mammalian forms of phospholipase D (PLD), PLD1 and PLD2 (IC50s = 6 and 20 nM, respectively).
-
GC13930
N-(p-amylcinnamoyl) Anthranilic Acid
phospholipase A2 (PLA2) inhibitor and TRP channel blocker
- GC14090 o-3M3FBS Inactive analog of m-3M3FBS (PLC activator)
- GC17420 OBAA OBAA is a potent phospholipase A2 (PLA2) inhibitor, with an IC50 of 70 nM.
-
GC49457
Oleoyl-Coenzyme A (sodium salt)
An acyl-CoA thioester
-
GC13276
Oleyloxyethyl Phosphorylcholine
PLA2 inhibitor
- GC61155 Omeprazole sodium Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders.
- GC64070 Omeprazole-d3-1
- GC14521 ONO-RS-082 reversible inhibitor of Ca2+-independent phospholipase A2
- GC44664 p-Nitrophenylphosphorylcholine p-Nitrophenylphosphorylcholine is a chromogenic substrate that is used to measure phospholipase C (PLC) activity.
-
GC16714
PACOCF3
CPLA2 and iPLA2 inhibitor
- GC44549 Palmitoyl thio-PC Thioester analogs of glycerophospholipids, in combination with Ellman's reagent, are convenient colorimetric substrates for the measurement of phospholipase (PL) activity.
- GC44794 Pyrrophenone The group IVA phospholipase A2 (PLA2), known as calcium-dependent cytosolic PLA2 (cPLA2), selectively releases arachidonic acid (AA) from membrane phospholipids, playing a central role in initiating the synthesis of prostaglandins (PGs) and leukotrienes (LTs).
- GC32768 Quinacrine dihydrochloride (Mepacrine dihydrochloride)
- GC63860 Rapanone Rapanone is a natural benzoquinone.
- GC41004 Rhamnetin Rhamnetin is a natural flavonoid that has been isolated from a variety of plants.
- GC12411 RHC 80267 diacylglycerol lipase inhibitor
- GC64306 ROC-0929 ROC-0929 (compound 13a) is a potent and selective inhibitor of secreted phospholipases A2 (sPLA2s) with an IC50 of 80 nM, specially targeting hGX.
-
GC69862
SB-435495
SB-435495 is an effective, selective, reversible, non-covalent and orally active inhibitor of Lp-PLA2 with an IC50 of 0.06 nM.
- GC50738 SGC 3027N
- GC40794 Sphinganine (d18:0) D-Erythro-dihydrosphingosin directly inhibits cytosolic phospholipase A2α (cPLA2α) activity.
- GC37674 SPK-601 SPK-601 (LMV-601) is an inhibitor of the phosphatidylcholine-specific phospholipase C (PC-PLC).
- GC44943 sPLA2 Inhibitor sPLA2 Inhibitor, a D-tyrosine derivative, is an orally active, potent secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 29 nM for human nonpancreatic secretory PLA2 isoform IIa (hnpsPLA2-IIa).
- GC30180 ST271 ST271 is a potent inhibitor of protein tyrosine kinase (PTK), inhibits phospholipase D activation stimulated by fMet-Leu-Phe and PAF, with IC50s of 6.7 and 9 μM, respectively.
- GC11520 ST638 tyrosine kinase inhibitor and PLD inhibitor